| # | Drug | Count |
|---|---|---|
| 0 | TOPOTECAN | 4 |
| 1 | DEXAMETHASONE | 3 |
| 2 | BEVACIZUMAB | 1 |
| 3 | CARBOPLATIN | 1 |
| 4 | ETOPOSIDE | 1 |
| 5 | MELPHALAN HYDROCHLORIDE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TOPOTECAN | 4 | 0.0007 |
| 1 | MELPHALAN HYDROCHLORIDE | 1 | 0.0000 |
| 2 | ETOPOSIDE | 1 | 0.0000 |
| 3 | DEXAMETHASONE | 3 | 0.0000 |
| 4 | BEVACIZUMAB | 1 | 0.0000 |
| 5 | CARBOPLATIN | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 4 |
| 1 | Corticosteroid [EPC] | 3 |
| 2 | Platinum-based Drug [EPC] | 1 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 4 | 0.0001 |
| 1 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 3 | Corticosteroid [EPC] | 3 | 0.0000 |